aldosterone has been researched along with Adverse Drug Event in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Early detection of adverse effects of novel therapies and understanding of their mechanisms could improve the safety and efficiency of drug development." | 2.87 | Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib. ( DeLisle, RK; Ganz, P; Hyde, C; Malarstig, A; Murthy, AC; Ostroff, R; Segal, MR; Weiss, SJ; Williams, SA, 2018) |
| "A syndrome termed hyporeninemic hypoaldosteronism, associated with hyperkalemia, has been frequently described in elderly patients." | 2.38 | Hyperkalemia in the elderly. ( Michelis, MF, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, SA | 1 |
| Murthy, AC | 1 |
| DeLisle, RK | 1 |
| Hyde, C | 1 |
| Malarstig, A | 1 |
| Ostroff, R | 1 |
| Weiss, SJ | 1 |
| Segal, MR | 1 |
| Ganz, P | 1 |
| Krapf, R | 1 |
| Michelis, MF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study (SomaSignal Study)[NCT04836117] | 200 participants (Anticipated) | Interventional | 2021-08-12 | Recruiting | |||
| Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjec[NCT00134264] | Phase 3 | 15,067 participants (Actual) | Interventional | 2004-07-31 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for aldosterone and Adverse Drug Event
| Article | Year |
|---|---|
[Iatrogenic hyperkalemia].
Topics: Aldosterone; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperkalemia; Iatrogenic Disea | 1996 |
Hyperkalemia in the elderly.
Topics: Aged; Aging; Aldosterone; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperkalemia; Hyp | 1990 |
1 trial available for aldosterone and Adverse Drug Event
| Article | Year |
|---|---|
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Chol | 2018 |